Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
Nina Friis‐Møller(University of Copenhagen), Andrew Phillips(Wake Forest University), Wafaa El‐Sadr(Columbia University Irving Medical Center), Rodolphe Thiébaut(Université de Bordeaux), Ole Kirk(University of Copenhagen), Éric Fontas(Université Côte d'Azur), Signe Westring Worm(University of Copenhagen), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Caroline Sabin(Primary Health Care), Peter Reiss(Amsterdam Institute for Global Health and Development), Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre)
European Journal of Cardiovascular Prevention & Rehabilitation
June 11, 2010
Cited by 392
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k